---
layout: post
title: 'Paper: Objective assessment of cancer genes for drug discovery'
date: '2013-01-02T04:45:00.001Z'
author: John Overington
tags:
- Books and Papers
modified_time: '2013-01-02T04:45:45.031Z'
thumbnail: http://3.bp.blogspot.com/-2x7x5KFCSxM/UOO66m0VkkI/AAAAAAAACjM/3FJiqjjOikM/s72-c/journal_cover201301.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6332820148918036463
blogger_orig_url: http://chembl.blogspot.com/2013/01/paper-objective-assessment-of-cancer.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-2x7x5KFCSxM/UOO66m0VkkI/AAAAAAAACjM/3FJiqjjOikM/s1600/journal_cover201301.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-2x7x5KFCSxM/UOO66m0VkkI/AAAAAAAACjM/3FJiqjjOikM/s1600/journal_cover201301.jpg" /></a></div>
<br />
<br />
There's a great paper just published in <a href="http://www.nature.com/nrd">NRDD</a> on the analysis of potential drug targets using an objective, evidence-based approach, it makes extensive use of <a href="http://www.ebi.ac.uk/chembl">ChEMBL</a> data, alongside specific cancer-related datasets, pathway and interaction data and so forth. There is also some good discussion of drug-repurposing informatics approaches.<br />
<br />
A link to the pdf of the paper is <a href="http://www.nature.com/nrd">here</a>.<br />
<br />
<pre>%T Objective assessment of cancer genes for drug discovery
%A M.N. Patel
%A M.D. Halling-Brown
%A J.E. Tym
%A P. Workman
%A B. Al-Lazikani
%J Nature Reviews Drug Discovery
%V 12
%P 35-50
%D 2013
%O doi:10.1038/nrd3913
</pre>
<br />
<u>Disclosure</u> - one of the authors of the above paper (Al-Lazikani) is my wife.<br />
<br />
jpo
